Navigation Links
Pfenex Inc. Launches reagentproteins.com
Date:11/2/2010

SAN DIEGO, Nov. 2, 2010 /PRNewswire/ -- Pfenex Inc. today announced the launch of a new business division, Reagent Proteins. Reagent Proteins will enhance the development scientists' ability to source complex reagent grade proteins at a competitive price.

Reagent Proteins will initially offer a product list in excess of 2300 proteins, including stem cell growth factors, cytokines, chemokines, and enzymes. A unique aspect of Reagent Proteins' offering includes vaccine carriers, adjuvants and antigens, available in both pre-clinical and cGMP quality grades. Reagent Proteins is the only protein supplier supporting human vaccine developers from discovery to commercialization with a broad range of vaccine components.

"As we continue to leverage our business based on efficient complex protein production, the Reagent Proteins business unit is an obvious choice," stated Bertrand C. Liang, Chief Executive Officer, "We have and continue to build a portfolio of proteins in areas of need, including those based upon monitoring of industry trends as well as direct feedback from the researchers themselves."

About Reagent Proteins

Reagent Proteins is a leading supplier of reagent, pre-clinical and cGMP grade proteins to the biopharmaceutical and vaccine development community. We ensure that scientists have ready access to a comprehensive offering of high quality proteins to enable their development efforts to proceed efficiently. www.reagentproteins.com

About Pfenex Inc.

Pfenex Inc. is a protein production company leveraging the unique and powerful Pfenex Expression Technology™ platform based on the microorganism, Pseudomonas fluorescens, for the production of research proteins, reagent proteins, biosimilars and innovator biopharmaceuticals. For more information please visit www.pfenex.com


'/>"/>
SOURCE Pfenex Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Adaptive TCR Launches the immunoSEQ™ Product Line - Visualizing the Immune System With Next-Generation Sequencing.
2. Prometheus Research Launches Solutions Group to Springboard HTSQL-based Solutions for Customers
3. Davis Phinney Foundation Launches Exercise-Focused Tools to Help People Live Well With Parkinsons Disease
4. CoreLab Partners Launches New DXA Imaging Service Offerings
5. Verenium Launches DELTAZYM® GA L-E5 Enzyme for Fuel Ethanol Production
6. InSightec Launches ExAblate(R) One and ExAblate(R) OR Systems at CIRSE 2010
7. Michael J. Fox Foundation Launches Parkinsons Progression Markers Initiative (PPMI)
8. HelixLife Launches Custom Health Supplements, Anti-Aging and Acne Skin Serums
9. Norgen Biotek Corp. Launches a Novel kit to Collect, Concentrate, Preserve and Isolate DNA, RNA, microRNA and proteins from Urine Specimens
10. Serono Symposia International Foundation (SSIF) Launches a New Web Site Dedicated to Medical Education on Phenylketonuria (PKU)
11. West Michigan Launches $10 Million Early Stage Venture Fund to Support Life Science & Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
(Date:10/10/2017)... ... October 10, 2017 , ... Dr. Bob Harman, founder and CEO ... Diego Rotary Club. The event entitled “Stem Cells and Their Regenerative ... attendees. Dr. Harman, DVM, MPVM was joined by two human doctors: Peter B. ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced ... the NIH to develop RealSeq®-SC (Single Cell), expected to ... profiling small RNAs (including microRNAs) from single cells using ... highlights the need to accelerate development of approaches to ... "New techniques for measuring levels of ...
(Date:10/10/2017)... ... October 10, 2017 , ... The Pittcon Program Committee ... honoring scientists who have made outstanding contributions to analytical chemistry and applied ... the world’s leading conference and exposition for laboratory science, which will be held ...
Breaking Biology Technology:
(Date:4/5/2017)... LONDON , April 4, 2017 KEY ... is anticipated to expand at a CAGR of 25.76% ... neurodegenerative diseases is the primary factor for the growth ... full report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The ... of product, technology, application, and geography. The stem cell ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... 30, 2017 The research team of The ... (3D) fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery ... of speed and accuracy for use in identification, crime investigation, immigration ... ... A research team ...
Breaking Biology News(10 mins):